ASPIASP Isotopes Inc.
Miscellaneous Chemical Products
- Revenue
- $24M
- 476% YoY
- Operating margin
- -251.2%
- 61% YoY
- EBITDA
- −$58M
- 124% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$160M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired67% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear1% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|
| Revenue | $0 | $433K | $4M | $24M | 476% |
| Operating income | −$5M | −$16M | −$26M | −$60M | 127% |
| Net income | −$5M | −$16M | −$32M | −$160M | 393% |
| Operating cash flow | −$3M | −$5M | −$17M | −$38M | 126% |
| Capex | $4M | $2M | $10M | $10M | 0.2% |
| Stock-based comp | $2M | $9M | $9M | $16M | 87% |
| Dividends | — | $0 | $3M | $0 | 100% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $62K · 2
- Open-market sells, 12 mo
- $1M · 8
- Net
- −$1M
Pay vs performance
No pay-versus-performance disclosure yet.